Helpful Insights

When it comes to pharmaceutical packaging, safety is no longer a “nice to have”. It’s non-negotiable. As medications become more widely used in homes, the responsibility to protect vulnerable users, especially children, has never been greater. At the same time, patients, caregivers, and healthcare professionals expect packaging that is intuitive, accessible, and convenient to use in everyday life.

The UK’s packaging Extended Producer Responsibility (EPR) framework is set to undergo significant changes in 2026, following the draft amendments laid out in November 2025. These updates will affect how producers manage packaging waste, report on recycling efforts, and work with Producer Responsibility Organisations (PROs) under PackUK. From the introduction of fee modulation based on packaging use to revised definitions for fibre-based composites, the new rules will bring both operational and financial implications for businesses across the country.

Fragile artwork, whether a delicate glass sculpture, a centuries-old painting, or a finely crafted ceramic piece, demands far more than standard packaging when it comes to transport and storage. Each item carries not only financial value but also cultural, historical, and emotional significance, making its protection critical. Even minor impacts, vibrations, or environmental changes can result in irreversible damage, underscoring the need for specialised protective packaging solutions at every stage of handling.

When it comes to transporting and storing heavy or irregular loads, standard strapping approaches often aren’t enough. These types of loads present unique challenges, from uneven weight distribution to awkward shapes that make them harder to secure effectively. Without the right approach, loads can shift during transit, place uneven stress on strapping materials, or become unstable altogether.

Pharmaceutical drug development is a complex, highly regulated and costly process. From early research through to clinical trials and regulatory approval, it can take many years, and significant investment, before a treatment reaches patients. Throughout this journey, attention is often focused on formulation, testing and regulatory milestones, while packaging decisions are sometimes left until the later stages of development.

When it comes to protective packaging, there’s a common misconception that more material automatically equals better protection. In reality, overstuffed boxes and excessive cushioning often mask underlying problems, and can even contribute to in-transit damage. Shifts, collisions, and pressure points inside the package are frequently the hidden culprits behind product damage. Extra material alone can’t solve these issues.

In the pharmaceutical industry, packaging is far more than a container. It is a critical safeguard for patient safety, regulatory compliance and product integrity across the entire supply chain. From the moment a medicine is produced to its arrival at hospitals, pharmacies or patients’ homes, each layer of packaging plays a vital role in protecting sensitive products from damage, contamination and tampering, while ensuring they reach their destination in perfect condition.

When it comes to food, first impressions matter just as much as the flavour. In the food industry, protective packaging isn’t just about keeping products fresh. It is a key factor in shaping the customer experience.

The manufacture of pharmaceuticals requires the highest quality standards at every stage – and that includes the packaging. With new regulations and technological innovations coming into play in 2025, the landscape is changing rapidly. Here we’ll look at four key developments – and how we can help you navigate them.